In the in vivo AD mouse model NKCC1 expression appeared to undergo layer and region-specific increases in the CA1 region, particularly in the CA1 injection site of Aβ1-42-injected mice 30-days post-injection. The gene discussed is SLC12A2; the disease is Alzheimer disease.